Monte Rosa Therapeutics, Inc. short interest in 2022
In 2022, Monte Rosa Therapeutics, Inc.'s disclosed short interest ran from 7.56% of shares outstanding on 14 Jan 2022 to 8.97% on 30 Dec 2022, a change of +1.41 percentage points. The year's high was 12.80% on 31 Mar 2022 and its low 7.33% on 31 Jan 2022, averaging 10.37% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 44.13 days on 30 Nov 2022. Full history: Monte Rosa Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 7.56% (14 Jan 2022)
- End of year
- 8.97% (30 Dec 2022)
- Change
- +1.41 pp
- High
- 12.80% (31 Mar 2022)
- Low
- 7.33% (31 Jan 2022)
- Average
- 10.37%
- Highest days to cover
- 44.13 (30 Nov 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 7.56% | 16.77 | |
| 31 Jan 2022 | 7.33% | 11.44 | |
| 15 Feb 2022 | 9.68% | 17.20 | |
| 28 Feb 2022 | 10.74% | 19.43 | |
| 15 Mar 2022 | 11.59% | 17.96 | |
| 31 Mar 2022 | 12.80% | 10.44 | 10-K filed, results (8-K) |
| 14 Apr 2022 | 12.37% | 36.43 | |
| 29 Apr 2022 | 12.15% | 40.27 | |
| 13 May 2022 | 12.12% | 34.50 | 10-Q filed, results (8-K) |
| 31 May 2022 | 12.26% | 35.30 | |
| 15 Jun 2022 | 10.58% | 19.18 | |
| 30 Jun 2022 | 9.98% | 13.00 | |
| 15 Jul 2022 | 9.91% | 41.12 | |
| 29 Jul 2022 | 9.90% | 43.96 | |
| 15 Aug 2022 | 10.22% | 22.27 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 10.90% | 27.99 | |
| 15 Sep 2022 | 10.52% | 22.29 | |
| 30 Sep 2022 | 11.01% | 10.92 | |
| 14 Oct 2022 | 10.33% | 33.87 | |
| 31 Oct 2022 | 10.44% | 32.83 | |
| 15 Nov 2022 | 9.65% | 22.49 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 9.01% | 44.13 | |
| 15 Dec 2022 | 8.84% | 30.55 | |
| 30 Dec 2022 | 8.97% | 32.29 |
See also: Monte Rosa Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.